Lisanti Capital Growth LLC lessened its position in RxSight, Inc. (NASDAQ:RXST – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 110,820 shares of the company’s stock after selling 12,385 shares during the quarter. Lisanti Capital Growth LLC […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the last […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) CFO Shelley B. Thunen sold 20,000 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $49.90, for a total transaction of $998,000.00. Following the completion of the sale, the chief financial officer now directly owns 8,402 shares […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) CFO Shelley B. Thunen sold 20,000 shares of RxSight stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $49.90, for a total value of $998,000.00. Following the completion of the sale, the chief financial officer now directly owns […]